Dose-effect relationship between blood flow and HIFU ablation of uterine fibroid with hypersignal on T2WI

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051386

Enrollment

Unknown

Registered

2021-09-22

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroid

Interventions

Heterochronous high signals group:None

Uniformly mildly high signal group:None

Uniform obvious high signal group:None

Eligibility

Sex/Gender

Female

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Premenopausal women over 18 years old; 2.Maximum diameter of myoma >= 5cm and <=10cm; 3.The ultrasound was able to clearly show the location of the uterine fibroid; 4.Preoperative magnetic resonance imaging showed the myoma was hypersignal T2WI; 5.The patient agreed to participate in the experiment.

Exclusion criteria

Exclusion criteria: 1.The number of target uterine fibroid is more than 2; 2.Women with the presence of a concomitant adenomyosis; 3.Power Doppler can not clearly show the blood flow signal of the blood supply artery of the uterine fibroid; 4.Women with contraindications to magnetic resonance imaging.

Design outcomes

Primary

Measure	Time frame
Non-perfused volume ratio;Systolic value;Peripheral and internal blood flow parameters of fibroids;Effect of high intensity focused ultrasound ablation;	—

Countries

China

Contacts

Public ContactChen Jinyun

Chongqing Medical University

chenjinyun2006@126.com+86 13668029697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026